|
Insulin/IGF
signaling (IIS) promotes growth and energy storage when nutrients are
abundant, but the life span of different eukaryotic organisms (mice,
Drosophila, C. elegans) is actually increased when IIS is
reduced by calorie restriction or by mutations in its pathway
components. It seems that resistance to oxidative stress underlies
this paradox. Environmental insults such as UV irradiation and
oxidative stress activate, among other molecules, Jun-N-terminal
kinase (JNK), a component of mitogen-activated protein kinase (MAPK)
cascade, that induces a protective gene expression profile and
thereby confers tolerance to oxidative stress and prolongs life span.
Wang and
colleagues studied the opposing effects of IIS and JNK on oxidative
stress tolerance and longevity in Drosophila. The Drosophila
genome contains 7 insulin-like peptides, of which dilp2 most
closely resembles human insulin. Dilp2 is secreted by
insulin-producing cells (IPC) that form a small cluster of
neuroendocrine cells in the fly brain. Specific elimination of IPCs
leads to growth retardation, developmental delays, and decreased
late-life mortality. Similar to humans, Drosophila IIS leads
to activation of PI3 kinase and Akt, which in turn phosphorylates the
Forkhead transcription factor, causing its cytoplasmic retention and
down-regulation of its target genes. The Drosophila Forkhead
transcription factor DFoxo extends lifespan when
over-expressed.
The authors
provided evidence that DFoxo is required for JNK-mediated life
span extension in Drosophila. Further, JNK signaling affected
DFoxo function as shown by modulation of DFoxo-dependent
phenotypes in eye development and expression of the DFoxo
target genes thor (a translational repressor that suppresses
growth when IIS is inactive) and l(2)efl (a small heat shock
protein that enhances survival of cells exposed to oxidative damage).
Finally, the authors found that JNK and DFoxo restrict IIS
systemically by repressing dilp2 expression in IPCs. When JNK
activity was specifically increased in the IPCs only, there was a
DFoxo-dependent decrease in body size and increase in life
span. Thus, the JNK-DFoxo effects on aging and lifespan occur
at 2 levels. In peripheral tissues, JNK activates DFoxo to
prevent senescence cell-autonomously through expression of genes
protective against oxidative damage (eg, preventing age-related
declines in cardiac or neurologic function). JNK activation of DFoxo
in IPCs represses dilp2 expression, thereby decreasing IIS
systemically and coordinating cellular responses to environmental
changes, which impacts the life span of the organism as a whole.
Wang
MC, Bohmann D, Jasper H. JNK extends life span and limits growth by
antagonizing cellular and organism-wide responses to insulin
signaling. Cell. 2005;121:115−125.
Editor’s
Comment: In this intriguing paper, the authors made a strong case
for Foxo being the convergence point of the opposing effects of IIS
and JNK activity on longevity and stress response in Drosophila. They
speculated whether Foxo homologs may play a similar role in mammals,
and they cited prior evidence that JNK can inhibit IIS by
phosphorylating and inhibiting the insulin receptor substrate.1,2
Another
unmentioned convergence point in mammals is the tumor suppressor,
p53. Inactive JNK binds the N-terminus of p53, leading to p53
ubiquitination and degradation; this is one of the principal
mechanisms by which the tumor suppressor is kept at very low
concentrations under normal circumstances. However, when JNK is
activated by radiation or oxidative stress, it phosphorylates p53 on
threonine 81, thereby activating it.3 By repressing
transcription of IGF-II and the IGF receptor while activating
transcription of IGF binding protein (IGFBP)-3, p53 directly
inhibits IGF signaling.4 As well, p53 has been implicated
in issues of senescence, longevity, and responses to nutrition and
stress. Mice harboring a carboxy-terminus p53 fragment that augments
activity of the wild-type p53 allele displayed enhanced resistance to
spontaneous tumors, but early onset of aging phenotypes, including
osteoporosis, lordokyphosis, generalized organ atrophy, decreased
stress tolerance and reduced longevity.5
Adda Grimberg, MD
References - (linked to )
-
Wang
MC, Bohmann D, Jasper H. JNK extends life span and limits growth by
antagonizing cellular and organism-wide responses to insulin
signaling. Cell.
2005;121:115-125.
-
Hirosumi J,
Tuncman G, Chang L, et al. A central role for JNK in obesity and
insulin resistance. Nature. 2002;420:333–336.
-
Lee YH,
Giraud J, Davis RJ, White MF. c-Jun N-terminal kinase (JNK) mediates
feedback inhibition of the insulin signaling cascade. J Biol
Chem. 2003;278: 2896–2902.
-
Pluquet
O, Hainaut P. Genotoxic and non-genotoxic pathways of p53
induction. Cancer Lett. 2001;174:1-15.
-
Grimberg A.
p53 and IGFBP-3: Apoptosis and Cancer Protection. Molec Genet
Metab. 2000;70:85-98.
-
Tyner SD,
Venkatachalam S, Choi J, et al. p53 mutant mice that display early
ageing-associated phenotypes. Nature. 2002;415:45-53.
|